Literature DB >> 17278062

A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species.

Anders Ternhag1, Tommi Asikainen, Johan Giesecke, Karl Ekdahl.   

Abstract

Eleven randomized, controlled trials of antibiotic treatment versus placebo in patients with Campylobacter species infection were pooled in a meta-analysis. Antibiotic treatment shortened the duration of intestinal symptoms by 1.32 days (95% confidence interval, 0.64-1.99; P<.0001). Because of problems with drug resistance, a restrictive attitude towards the administration of antibiotics in uncomplicated cases is advised.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17278062     DOI： 10.1086/509924

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  33 in total

1.  Infectious diarrhea: when to test and when to treat.

Authors:  Todd F Hatchette; Dana Farina
Journal:  CMAJ       Date:  2010-12-20       Impact factor: 8.262

Review 2.  Management of bloody diarrhoea in children in primary care.

Authors:  M Stephen Murphy
Journal:  BMJ       Date:  2008-05-03

3.  Optimal treatment of campylobacter dysentery.

Authors:  Lea S Eiland; Lauren S Jenkins
Journal:  J Pediatr Pharmacol Ther       Date:  2008-07

4.  Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections.

Authors:  Peter Ankomah; Bruce R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

Review 5.  Human Campylobacteriosis-A Serious Infectious Threat in a One Health Perspective.

Authors:  Markus M Heimesaat; Steffen Backert; Thomas Alter; Stefan Bereswill
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

6.  Correlation between flagellin A (flaA) genotypes and antimicrobial susceptibility patterns of Campylobacter jejuni strains isolated from children with gastroenteritis in Athens, Greece.

Authors:  Anastassios Ioannidis; Chrysoula Nicolaou; Stylianos Chatzipanagiotou
Journal:  Mol Diagn Ther       Date:  2009-12-01       Impact factor: 4.074

7.  Recrudescent Campylobacter jejuni infection in an immunocompetent adult following experimental infection with a well-characterized organism.

Authors:  Shahida Baqar; David R Tribble; Marya Carmolli; Katrin Sadigh; Frederic Poly; Chad Porter; Catherine J Larsson; Kristen K Pierce; Patricia Guerry; Michael Darsley; Beth Kirkpatrick
Journal:  Clin Vaccine Immunol       Date:  2009-11-18

8.  Failure of Syndrome-Based Diarrhea Management Guidelines to Detect Shigella Infections in Kenyan Children.

Authors:  P B Pavlinac; D M Denno; G C John-Stewart; F M Onchiri; J M Naulikha; E A Odundo; C E Hulseberg; B O Singa; L E Manhart; J L Walson
Journal:  J Pediatric Infect Dis Soc       Date:  2015-07-12       Impact factor: 3.164

9.  Comparison of disk diffusion and agar dilution methods for erythromycin, ciprofloxacin, and tetracycline susceptibility testing of Campylobacter coli and for tetracycline susceptibility testing of Campylobacter jejuni subsp. jejuni.

Authors:  Christiane Gaudreau; Yves Girouard; Huguette Gilbert; Josée Gagnon; Sadjia Bekal
Journal:  Antimicrob Agents Chemother       Date:  2008-10-06       Impact factor: 5.191

10.  2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.

Authors:  Andi L Shane; Rajal K Mody; John A Crump; Phillip I Tarr; Theodore S Steiner; Karen Kotloff; Joanne M Langley; Christine Wanke; Cirle Alcantara Warren; Allen C Cheng; Joseph Cantey; Larry K Pickering
Journal:  Clin Infect Dis       Date:  2017-11-29       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.